Electronic Warning System for Atrial Fibrillation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02455102|
Recruitment Status : Completed
First Posted : May 27, 2015
Last Update Posted : December 22, 2015
|Condition or disease||Intervention/treatment||Phase|
|Atrial Fibrillation||Other: Electronic warning alert||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||1707 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Electronic Warning System to Improve Stroke Prevention in Atrial Fibrillation - A Quality Improvement Initiative at the University Hospital Bern|
|Study Start Date :||September 2014|
|Actual Primary Completion Date :||October 2015|
|Actual Study Completion Date :||October 2015|
Active Comparator: Electronic alert
Physicians, whose patients with atrial fibrillation do not receive stroke preventive measures, will receive an electronic warning alert.
Other: Electronic warning alert
A newly-installed warning system for stroke prevention in atrial fibrillation.
No Intervention: No electronic alert
Physicians, whose patients with atrial fibrillation do not receive stroke preventive measures, will receive no electronic warning alert.
- Rate of initiation of adequate measures to prevent stroke (oral anticoagulant prescription) by physician in charge [ Time Frame: End of hospital stay (expected average duration of 1 week) ]Reviewed from discharge letter
- Use of the CHA2DS2VASc score calculation tool by the physician in charge [ Time Frame: During hospital stay (expected average duration of 1 week) ]
- Rate of correct evaluation of the CHA2DS2VASC Score through the calculation tool by physician in charge [ Time Frame: End of hospital stay (expected average duration of 1 week) ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02455102
|Swiss Cardiovascular Center, Inselspital, University of Bern|
|Bern, Switzerland, 3012|
|Principal Investigator:||Nils Kucher, Prof. M.D.||Department of Angiology, Swiss Cardiovascular Center, University of Berne|